Brussels, 26 June 2026 - EuropaBio welcomes the European CRO Federation (EUCROF) as its newest associate member.

Founded in 2005 and registered in the Netherlands, EUCROF represents contract research organisations (CROs) and engages with regulators, industry and healthcare stakeholders to support high-quality clinical research in Europe.

EUCROF works to enhance the quality and impact of clinical research and actively contributes to European initiatives through its engagement with the European Medicines Agency (EMA), including the EU Clinical Trial Information System, ACT EU and the Biotech Act.

In joining EuropaBio, EUCROF seeks to strengthen collaboration at European level and contribute its operational and regulatory expertise to policy discussions, particularly in relation to the EU Biotech Act and clinical research legislation.

Dr. Claire Skentelbery, Director General of EuropaBio, said: “EUCROF brings an important representative voice into EuropaBio, speaking for CROs and the full landscape for clinical trials delivery in the EU. It comes at a critical legislative period for the effectiveness of clinical trials and EUCROF expertise can ensure that they work for all.”

Yoanni Matsakis, President of EUCROF, said: "At a time when all stakeholders in European clinical research, whether public, institutional, or private, must actively cooperate to strengthen European competitiveness, joining EuropaBio seemed a natural step. EuropaBio provides en extremely powerful environment and EUCROF brings its successful experience with the only transnational GDPR code of conduct in the Heath area, applicable in all 27 EU Member States, and its unique operational and regulatory expertise across the entire field of clinical studies.”